Search Results for: CAR

By Kuldip K. Ambastha Carnival Corporation (CCL) is well-known as a cruise operator and as a prominent travel / leisure company. This British-American company has struggled recently due to the coronavirus pandemic seen worldwide. However, during this week, the company had strong days on Monday, April 6, 2020 and Tuesday, April 7, 2020, returning 20.3% …

Continue reading “What Caught Our Attention in the Investment World? – Week of April 6-10, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha On Friday, January 3, 2020, Tesla, Inc. (TSLA) delivered a gain of 3.0% closing at an all-time high of $443.01 per share due to positive news. Intra-day, the share price reached as high as $454.00 per share. Tesla beat Wall Street estimates for both car production and …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 30, 2019 – January 3, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On October 22, 2019, Biogen Inc. (BIIB) delivered a 26.1% return for the day. This was the stock’s largest one-day percentage return in 23 years. Its Alzheimer’s drug (aducanumab) had previously been written off as a failure, but now will be getting a second chance at approval …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 21-25, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha During this trading week, JP Morgan Chase & Co. (JPM) was a star performer. Specifically, the company delivered on many fronts, in terms of strong underwriting data, an increase in mortgage banking activities, significant bond trading income, substantial wholesale and credit card loans, and positive home lending …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 14-18, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 9-13, 2019”